Brookline Capital Acquisition Corp.

As of July 29, 2022, Brookline Capital Acquisition Corp. was acquired by Apexigen, Inc., in a reverse merger transaction. As of August 1, 2022, Brookline Capital Acquisition Corp. was acquired by Apexigen Inc., in a reverse merger transaction. Brookline Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to acquire companies in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.